Copyright
©The Author(s) 2015.
World J Rheumatol. Jul 12, 2015; 5(2): 108-126
Published online Jul 12, 2015. doi: 10.5499/wjr.v5.i2.108
Published online Jul 12, 2015. doi: 10.5499/wjr.v5.i2.108
N study | Ref. | Selection | Comparability | Results | Total | |||||
Representati-veness of the cases | Selection of controls | Ascertain-ment of exposure | Demonstration that outcome of interest was not present at start of study | Comparability of cohorts on the basis of the design or analysis | Assessment of outcome | Was follow-up long enough for outcomes to occur | Adequacy of follow up of cohorts | |||
1 | Geborek et al[12] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 1 | 8 |
2 | Van Vollenhoven et al[13] | 0 | 1 | 1 | 1 | 2 | 0 | 1 (24 mo) | 0 | 6 |
3 | Cohen et al[14] | 1 | 1 | 1 | 1 | 1 | 0 | 1 (3 mo) | 0 | 6 |
4 | Finckh et al[15] | 1 | 1 | 1 | 0 | 1 | 1 | 1 (12 mo) | 1 | 7 |
5 | Heiberg et al[16] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 1 | 8 |
6 | Hyrich et al[17,18] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 1 | 8 |
7 | Kristensen et al[19] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (36 mo) | 0 | 6 |
8 | Bernal Rivera et al[20] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (12 mo ) | 1 | 7 |
9 | Fernández-Nebro et al[21] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 1 | 8 |
10 | Radstake et al[23] | 0 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 0 | 6 |
11 | Kievit et al[22] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 0 | 7 |
12 | Bazzani et al[24] | 1 | 1 | 1 | 0 | 2 | 1 | 1 (6 mo) | 1 | 8 |
13 | Greenwood et al[47] | 0 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 0 | 6 |
14 | Laas et al[25] | 1 | 1 | 1 | 1 | 2 | 1 | 1 (3 mo) | 1 | 9 |
15 | Arenere Mendoza et al[26] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 0 | 7 |
16 | Buch et al[46] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (6 mo) | 0 | 6 |
17 | Canhão et al[27] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (12 mo) | 1 | 7 |
18 | Hetland et al[28] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 1 | 8 |
19 | Blom et al[29] | 1 | 1 | 1 | 1 | 2 | 1 | 1 (12 mo) | 1 | 9 |
20 | Chatzidionysiou et al[30] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 0 | 7 |
21 | Gotenberg et al[45] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 1 | 8 |
22 | Iannone et al[32] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (48 mo) | 0 | 6 |
23 | Leffers et al[33] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 0 | 7 |
24 | Martínez-Pérez et al[44] | 0 | 1 | 0 | 1 | 2 | 0 | 1 (12 mo) | 0 | 5 |
25 | Wakabayashi et al[34] | 0 | 1 | 1 | 1 | 2 | 1 | 1 (12 mo) | 1 | 8 |
26 | Finckh et al[36] | 1 | 1 | 1 | 1 | 1 | 1 | 1 (24 mo) | 1 | 8 |
27 | Gomez-Reino et al[35] | 1 | 1 | 1 | 0 | 2 | 1 | 1 (12 mo) | 1 | 8 |
28 | Greenberg et al[37] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (24 mo) | 1 | 8 |
29 | Kekow et al[38] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (6 mo) | 1 | 8 |
30 | Schabert et al[39] | 1 | 1 | 1 | 1 | 1 | 1 | 1 (12 mo) | 1 | 8 |
31 | Chatzidionysiou et al[40] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (6 mo) | 0 | 6 |
32 | Keystone et al[43] | 0 | 1 | 1 | 0 | 2 | 0 | 1 (12 mo) | 0 | 5 |
33 | Emery et al[41] | 1 | 1 | 1 | 0 | 2 | 0 | 1(12 mo) | 0 | 6 |
34 | Flouri et al[42] | 1 | 1 | 1 | 1 | 2 | 0 | 1 (12 mo) | 1 | 8 |
35 | Harrold et al[31] | 1 | 1 | 1 | 0 | 2 | 0 | 1 (12 mo) | 0 | 6 |
- Citation: Santos JBD, Costa JO, Junior HAO, Lemos LLP, Araújo VE, Machado MA&, Almeida AM, Acurcio FA, Alvares J. What is the best biological treatment for rheumatoid arthritis? A systematic review of effectiveness. World J Rheumatol 2015; 5(2): 108-126
- URL: https://www.wjgnet.com/2220-3214/full/v5/i2/108.htm
- DOI: https://dx.doi.org/10.5499/wjr.v5.i2.108